25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Teva Pharmaceutical Industries Ltd
Buy, Hold or Sell?

Let's analyze Teva Pharmaceutical Industries Ltd together

I guess you are interested in Teva Pharmaceutical Industries Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Teva Pharmaceutical Industries Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Teva Pharmaceutical Industries Ltd

I send you an email if I find something interesting about Teva Pharmaceutical Industries Ltd.

1. Quick Overview

1.1. Quick analysis of Teva Pharmaceutical Industries Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Teva Pharmaceutical Industries Ltd? (30 sec.)

How much money do you get?

How much money do you get?
ILA0.00
When do you have the money?
1 year
How often do you get paid?
52.5%

What is your share worth?

Current worth
ILA2,149.57
Expected worth in 1 year
ILA1,774.55
How sure are you?
47.5%

+ What do you gain per year?

Total Gains per Share
ILA-375.02
Return On Investment
-5.9%

For what price can you sell your share?

Current Price per Share
ILA6,340.00
Expected price per share
ILA5,849 - ILA7,323
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Teva Pharmaceutical Industries Ltd (5 min.)




Live pricePrice per Share (EOD)
ILA6,340.00
Intrinsic Value Per Share
ILA-5,079.91 - ILA8,318.77
Total Value Per Share
ILA-2,930.34 - ILA10,468.34

2.2. Growth of Teva Pharmaceutical Industries Ltd (5 min.)




Is Teva Pharmaceutical Industries Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$6.5b$8.6b-$1.1b-16.1%

How much money is Teva Pharmaceutical Industries Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$119m-$558.2m$439.2m369.1%
Net Profit Margin-3.1%-14.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Teva Pharmaceutical Industries Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Teva Pharmaceutical Industries Ltd?

Welcome investor! Teva Pharmaceutical Industries Ltd's management wants to use your money to grow the business. In return you get a share of Teva Pharmaceutical Industries Ltd.

First you should know what it really means to hold a share of Teva Pharmaceutical Industries Ltd. And how you can make/lose money.

Speculation

The Price per Share of Teva Pharmaceutical Industries Ltd is ILA6,340. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Teva Pharmaceutical Industries Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Teva Pharmaceutical Industries Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ILA2,149.57. Based on the TTM, the Book Value Change Per Share is ILA-93.75 per quarter. Based on the YOY, the Book Value Change Per Share is ILA-173.59 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ILA0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Teva Pharmaceutical Industries Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per Share
Usd Eps-0.750.0%-0.110.0%-0.640.0%-0.340.0%-0.320.0%
Usd Book Value Change Per Share-0.870.0%-0.250.0%-0.470.0%-0.380.0%-0.380.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.250.0%
Usd Total Gains Per Share-0.870.0%-0.250.0%-0.470.0%-0.380.0%-0.130.0%
Usd Price Per Share16.49-12.78-8.11-9.29-23.67-
Price to Earnings Ratio-5.52-2.43-7.50-7.90-13.86-
Price-to-Total Gains Ratio-19.07--21.77--42.66--14.16-2.79-
Price to Book Ratio2.85-1.99-1.07-1.10-1.89-
Price-to-Total Gains Ratio-19.07--21.77--42.66--14.16-2.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share17.0863
Number of shares58
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.25-0.38
Usd Total Gains Per Share-0.25-0.38
Gains per Quarter (58 shares)-14.65-21.97
Gains per Year (58 shares)-58.62-87.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-59-691-89-98
20-117-1282-178-186
30-176-1873-267-274
40-234-2464-356-362
50-293-3055-445-450
60-352-3646-534-538
70-410-4237-623-626
80-469-4829-712-714
90-528-54110-801-802
100-586-60011-889-890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%4.08.00.033.3%10.010.00.050.0%22.018.00.055.0%61.018.04.073.5%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%17.023.00.042.5%49.034.00.059.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%2.00.018.010.0%21.00.019.052.5%57.00.026.068.7%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%19.021.00.047.5%58.025.00.069.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Teva Pharmaceutical Industries Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---320.978-93.755-71%-173.590-46%-142.262-56%-139.412-57%
Book Value Per Share--2149.5682435.418-12%2827.224-24%3445.466-38%5528.712-61%
Current Ratio--0.8920.951-6%1.042-14%1.018-12%0.770+16%
Debt To Asset Ratio--0.8410.825+2%0.803+5%0.783+7%0.696+21%
Debt To Equity Ratio--5.4695.002+9%4.471+22%4.018+36%2.969+84%
Dividend Per Share----0%-0%1.703-100%92.896-100%
Eps---277.089-38.976-86%-236.721-15%-124.608-55%-117.338-58%
Free Cash Flow Per Share--1.96555.598-96%96.048-98%50.619-96%293.844-99%
Free Cash Flow To Equity Per Share---314.427-130.192-59%-7.206-98%-112.571-64%645.962-149%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8318.771--------
Intrinsic Value_10Y_min---5079.906--------
Intrinsic Value_1Y_max--1127.471--------
Intrinsic Value_1Y_min--125.326--------
Intrinsic Value_3Y_max--3163.631--------
Intrinsic Value_3Y_min---170.656--------
Intrinsic Value_5Y_max--4929.802--------
Intrinsic Value_5Y_min---1064.089--------
Market Cap7182649095680.000+3%6933408906240.0005373108674848.000+29%3407509908128.000+103%3905763705017.600+78%13462378255486.199-48%
Net Profit Margin---0.203-0.031-85%-0.144-29%-0.098-52%-0.121-40%
Operating Margin----0%0.131-100%0.126-100%0.106-100%
Operating Ratio--1.3181.296+2%1.377-4%1.343-2%1.108+19%
Pb Ratio2.949+3%2.8471.986+43%1.070+166%1.095+160%1.893+50%
Pe Ratio-5.720-4%-5.5222.429-327%7.496-174%7.900-170%13.858-140%
Price Per Share6340.000+3%6120.0004742.750+29%3007.750+103%3447.550+78%8783.425-30%
Price To Free Cash Flow Ratio806.546+3%778.559186.224+318%2.453+31638%17.475+4355%12.186+6289%
Price To Total Gains Ratio-19.752-4%-19.067-21.772+14%-42.657+124%-14.157-26%2.792-783%
Quick Ratio--0.2890.279+4%0.319-9%0.348-17%0.382-24%
Return On Assets---0.020-0.003-85%-0.013-37%-0.008-60%-0.009-56%
Return On Equity---0.133-0.021-84%-0.074-44%-0.045-66%-0.046-66%
Total Gains Per Share---320.978-93.755-71%-173.590-46%-140.559-56%-46.517-86%
Usd Book Value--6563043972.1007435799819.525-12%8632057834.400-24%10519670481.320-38%17762694009.253-63%
Usd Book Value Change Per Share---0.865-0.253-71%-0.468-46%-0.383-56%-0.376-57%
Usd Book Value Per Share--5.7936.563-12%7.619-24%9.286-38%14.900-61%
Usd Dividend Per Share----0%-0%0.005-100%0.250-100%
Usd Eps---0.747-0.105-86%-0.638-15%-0.336-55%-0.316-58%
Usd Free Cash Flow--6000040.200169751137.325-96%293251964.775-98%154551035.485-96%987256614.575-99%
Usd Free Cash Flow Per Share--0.0050.150-96%0.259-98%0.136-96%0.792-99%
Usd Free Cash Flow To Equity Per Share---0.847-0.351-59%-0.019-98%-0.303-64%1.741-149%
Usd Market Cap19357239312.858+3%18685537002.31714480527878.715+29%9183239202.405+103%10526033185.022+78%36281109398.535-48%
Usd Price Per Share17.086+3%16.49312.782+29%8.106+103%9.291+78%23.671-30%
Usd Profit---846005668.200-119000797.300-86%-558253740.275-34%-383702570.790-55%-585078920.003-31%
Usd Revenue--4164027898.8004072527285.750+2%3754525155.150+11%3977326647.910+5%4565030585.500-9%
Usd Total Gains Per Share---0.865-0.253-71%-0.468-46%-0.379-56%-0.125-86%
 EOD+4 -4MRQTTM+7 -25YOY+7 -265Y+6 -2910Y+3 -32

3.3 Fundamental Score

Let's check the fundamental score of Teva Pharmaceutical Industries Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.720
Price to Book Ratio (EOD)Between0-12.949
Net Profit Margin (MRQ)Greater than0-0.203
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.289
Current Ratio (MRQ)Greater than10.892
Debt to Asset Ratio (MRQ)Less than10.841
Debt to Equity Ratio (MRQ)Less than15.469
Return on Equity (MRQ)Greater than0.15-0.133
Return on Assets (MRQ)Greater than0.05-0.020
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Teva Pharmaceutical Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.207
Ma 20Greater thanMa 506,575.900
Ma 50Greater thanMa 1006,636.720
Ma 100Greater thanMa 2006,524.730
OpenGreater thanClose6,335.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Fundamental data was last updated by Penke on 2024-11-08 10:30:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Teva Pharmaceutical Industries Ltd earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Teva Pharmaceutical Industries Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -20.3% means that -0.20 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is -20.3%. The company is making a huge loss. -2
  • The TTM is -3.1%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-20.3%TTM-3.1%-17.3%
TTM-3.1%YOY-14.4%+11.4%
TTM-3.1%5Y-9.8%+6.8%
5Y-9.8%10Y-12.1%+2.3%
4.3.1.2. Return on Assets

Shows how efficient Teva Pharmaceutical Industries Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Teva Pharmaceutical Industries Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.0% Return on Assets means that Teva Pharmaceutical Industries Ltd generated -0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is -2.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-0.3%-1.7%
TTM-0.3%YOY-1.3%+1.0%
TTM-0.3%5Y-0.8%+0.5%
5Y-0.8%10Y-0.9%+0.1%
4.3.1.3. Return on Equity

Shows how efficient Teva Pharmaceutical Industries Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Teva Pharmaceutical Industries Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -13.3% Return on Equity means Teva Pharmaceutical Industries Ltd generated -0.13 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is -13.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.3%TTM-2.1%-11.2%
TTM-2.1%YOY-7.4%+5.3%
TTM-2.1%5Y-4.5%+2.4%
5Y-4.5%10Y-4.6%+0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Teva Pharmaceutical Industries Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Teva Pharmaceutical Industries Ltd is operating .

  • Measures how much profit Teva Pharmaceutical Industries Ltd makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Teva Pharmaceutical Industries Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY13.1%-13.1%
TTM-5Y12.6%-12.6%
5Y12.6%10Y10.6%+2.0%
4.3.2.2. Operating Ratio

Measures how efficient Teva Pharmaceutical Industries Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.32 means that the operating costs are 1.32 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is 1.318. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.296. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.318TTM1.296+0.021
TTM1.296YOY1.377-0.080
TTM1.2965Y1.343-0.046
5Y1.34310Y1.108+0.234
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Teva Pharmaceutical Industries Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Teva Pharmaceutical Industries Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.89 means the company has 0.89 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is 0.892. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.951. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.892TTM0.951-0.059
TTM0.951YOY1.042-0.091
TTM0.9515Y1.018-0.066
5Y1.01810Y0.770+0.248
4.4.3.2. Quick Ratio

Measures if Teva Pharmaceutical Industries Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Teva Pharmaceutical Industries Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.29 means the company can pay off 0.29 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is 0.289. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.279. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.289TTM0.279+0.010
TTM0.279YOY0.319-0.040
TTM0.2795Y0.348-0.069
5Y0.34810Y0.382-0.034
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Teva Pharmaceutical Industries Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Teva Pharmaceutical Industries Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Teva Pharmaceutical Industries Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.84 means that Teva Pharmaceutical Industries Ltd assets are financed with 84.1% credit (debt) and the remaining percentage (100% - 84.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is 0.841. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.825. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.841TTM0.825+0.016
TTM0.825YOY0.803+0.022
TTM0.8255Y0.783+0.042
5Y0.78310Y0.696+0.088
4.5.4.2. Debt to Equity Ratio

Measures if Teva Pharmaceutical Industries Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Teva Pharmaceutical Industries Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 546.9% means that company has 5.47 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Teva Pharmaceutical Industries Ltd:

  • The MRQ is 5.469. The company is unable to pay all its debts with equity. -1
  • The TTM is 5.002. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ5.469TTM5.002+0.466
TTM5.002YOY4.471+0.531
TTM5.0025Y4.018+0.984
5Y4.01810Y2.969+1.049
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Teva Pharmaceutical Industries Ltd generates.

  • Above 15 is considered overpriced but always compare Teva Pharmaceutical Industries Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -5.52 means the investor is paying -5.52 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Teva Pharmaceutical Industries Ltd:

  • The EOD is -5.720. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.522. Based on the earnings, the company is expensive. -2
  • The TTM is 2.429. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-5.720MRQ-5.522-0.198
MRQ-5.522TTM2.429-7.951
TTM2.429YOY7.496-5.067
TTM2.4295Y7.900-5.471
5Y7.90010Y13.858-5.958
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Teva Pharmaceutical Industries Ltd:

  • The EOD is 806.546. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 778.559. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 186.224. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD806.546MRQ778.559+27.987
MRQ778.559TTM186.224+592.335
TTM186.224YOY2.453+183.771
TTM186.2245Y17.475+168.748
5Y17.47510Y12.186+5.289
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Teva Pharmaceutical Industries Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Teva Pharmaceutical Industries Ltd:

  • The EOD is 2.949. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.847. Based on the equity, the company is underpriced. +1
  • The TTM is 1.986. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.949MRQ2.847+0.102
MRQ2.847TTM1.986+0.861
TTM1.986YOY1.070+0.917
TTM1.9865Y1.095+0.891
5Y1.09510Y1.893-0.798
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets41,338,000
Total Liabilities34,775,000
Total Stockholder Equity6,359,000
 As reported
Total Liabilities 34,775,000
Total Stockholder Equity+ 6,359,000
Total Assets = 41,338,000

Assets

Total Assets41,338,000
Total Current Assets11,632,000
Long-term Assets29,706,000
Total Current Assets
Cash And Cash Equivalents 2,258,000
Net Receivables 3,766,000
Inventory 3,927,000
Other Current Assets 516,000
Total Current Assets  (as reported)11,632,000
Total Current Assets  (calculated)10,467,000
+/- 1,165,000
Long-term Assets
Property Plant Equipment 5,931,000
Goodwill 16,488,000
Intangible Assets 4,853,000
Long-term Assets Other 434,000
Long-term Assets  (as reported)29,706,000
Long-term Assets  (calculated)27,706,000
+/- 2,000,000

Liabilities & Shareholders' Equity

Total Current Liabilities13,037,000
Long-term Liabilities21,738,000
Total Stockholder Equity6,359,000
Total Current Liabilities
Short Long Term Debt 2,094,000
Accounts payable 2,366,000
Other Current Liabilities 1,545,000
Total Current Liabilities  (as reported)13,037,000
Total Current Liabilities  (calculated)6,005,000
+/- 7,032,000
Long-term Liabilities
Long term Debt 16,547,000
Capital Lease Obligations Min Short Term Debt281,000
Long-term Liabilities Other 4,357,000
Long-term Liabilities  (as reported)21,738,000
Long-term Liabilities  (calculated)21,185,000
+/- 553,000
Total Stockholder Equity
Total Stockholder Equity (as reported)6,359,000
Total Stockholder Equity (calculated)0
+/- 6,359,000
Other
Capital Stock58,000
Common Stock Shares Outstanding 1,132,641
Net Debt 16,383,000
Net Invested Capital 25,000,000
Net Working Capital -1,405,000
Property Plant and Equipment Gross 5,931,000



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312002-12-312002-06-302001-12-312001-06-302000-12-312000-06-30
> Total Assets 
2,380,409
2,855,618
2,844,744
3,460,152
3,787,000
4,626,800
8,561,400
8,774,900
9,098,900
9,632,000
9,515,700
9,436,000
9,667,100
10,387,400
18,362,600
19,368,900
20,005,600
20,471,000
21,027,000
21,746,000
22,495,000
23,412,000
24,632,000
25,020,000
24,967,000
32,904,000
32,243,000
32,251,000
33,295,000
33,810,000
34,051,000
35,185,000
39,036,000
38,152,000
39,253,000
40,157,000
41,278,000
50,142,000
50,470,000
48,881,000
49,580,000
50,609,000
48,069,000
47,503,000
47,850,000
47,508,000
46,892,000
46,734,000
46,608,000
46,420,000
46,951,000
50,371,000
48,625,000
54,258,000
55,126,000
57,920,000
98,747,000
92,890,000
91,276,000
86,355,000
86,082,000
70,615,000
69,181,000
67,030,000
65,061,000
60,683,000
59,854,000
59,424,000
57,246,000
57,470,000
55,330,000
54,991,000
49,737,000
50,640,000
49,004,000
49,195,000
47,851,000
47,666,000
47,059,000
45,932,000
44,252,000
44,006,000
43,456,000
43,095,000
42,088,000
43,479,000
42,773,000
41,338,000
41,338,00042,773,00043,479,00042,088,00043,095,00043,456,00044,006,00044,252,00045,932,00047,059,00047,666,00047,851,00049,195,00049,004,00050,640,00049,737,00054,991,00055,330,00057,470,00057,246,00059,424,00059,854,00060,683,00065,061,00067,030,00069,181,00070,615,00086,082,00086,355,00091,276,00092,890,00098,747,00057,920,00055,126,00054,258,00048,625,00050,371,00046,951,00046,420,00046,608,00046,734,00046,892,00047,508,00047,850,00047,503,00048,069,00050,609,00049,580,00048,881,00050,470,00050,142,00041,278,00040,157,00039,253,00038,152,00039,036,00035,185,00034,051,00033,810,00033,295,00032,251,00032,243,00032,904,00024,967,00025,020,00024,632,00023,412,00022,495,00021,746,00021,027,00020,471,00020,005,60019,368,90018,362,60010,387,4009,667,1009,436,0009,515,7009,632,0009,098,9008,774,9008,561,4004,626,8003,787,0003,460,1522,844,7442,855,6182,380,409
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,961,000
14,835,000
14,595,000
16,226,000
15,382,000
14,687,000
14,711,000
13,881,000
13,794,000
13,431,000
13,805,000
12,542,000
13,464,000
12,884,000
12,781,000
12,160,000
13,005,000
12,401,000
12,822,000
12,154,000
12,573,000
12,451,000
12,164,000
11,453,000
12,051,000
11,501,000
12,088,000
11,425,000
12,485,000
12,297,000
11,632,000
11,632,00012,297,00012,485,00011,425,00012,088,00011,501,00012,051,00011,453,00012,164,00012,451,00012,573,00012,154,00012,822,00012,401,00013,005,00012,160,00012,781,00012,884,00013,464,00012,542,00013,805,00013,431,00013,794,00013,881,00014,711,00014,687,00015,382,00016,226,00014,595,00014,835,00016,961,000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
988,000
900,000
599,000
680,000
963,000
1,418,000
1,861,000
1,875,000
1,782,000
1,973,000
2,165,000
1,241,000
1,975,000
1,804,000
2,402,000
1,827,000
2,177,000
1,743,000
2,436,000
2,045,000
2,165,000
2,175,000
2,058,000
2,225,000
2,801,000
2,143,000
2,669,000
2,249,000
3,226,000
2,991,000
2,258,000
2,258,0002,991,0003,226,0002,249,0002,669,0002,143,0002,801,0002,225,0002,058,0002,175,0002,165,0002,045,0002,436,0001,743,0002,177,0001,827,0002,402,0001,804,0001,975,0001,241,0002,165,0001,973,0001,782,0001,875,0001,861,0001,418,000963,000680,000599,000900,000988,000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
679,000
0
0
0
14,000
0
0
0
2,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000002,00000014,000000679,000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
592,621
680,818
0
817,591
0
1,074,700
0
0
0
1,874,300
0
0
0
2,180,000
2,865,400
3,583,700
3,698,400
2,922,000
2,772,000
3,051,000
3,277,000
3,546,000
3,600,000
3,784,000
3,916,000
4,653,000
4,134,000
4,376,000
4,689,000
5,019,000
5,136,000
4,985,000
5,228,000
5,476,000
5,576,000
5,469,000
5,605,000
6,213,000
6,056,000
5,430,000
5,782,000
5,572,000
5,416,000
5,305,000
5,191,000
5,338,000
5,275,000
5,389,000
5,410,000
5,408,000
5,508,000
5,568,000
5,275,000
5,350,000
5,188,000
5,374,000
8,071,000
7,523,000
7,264,000
7,320,000
7,424,000
7,128,000
6,289,000
6,061,000
5,665,000
5,822,000
5,108,000
5,260,000
5,254,000
5,676,000
5,189,000
4,545,000
4,385,000
4,581,000
4,572,000
4,488,000
4,046,000
4,529,000
4,253,000
4,471,000
3,730,000
3,696,000
3,435,000
3,539,000
3,385,000
3,408,000
3,456,000
3,766,000
3,766,0003,456,0003,408,0003,385,0003,539,0003,435,0003,696,0003,730,0004,471,0004,253,0004,529,0004,046,0004,488,0004,572,0004,581,0004,385,0004,545,0005,189,0005,676,0005,254,0005,260,0005,108,0005,822,0005,665,0006,061,0006,289,0007,128,0007,424,0007,320,0007,264,0007,523,0008,071,0005,374,0005,188,0005,350,0005,275,0005,568,0005,508,0005,408,0005,410,0005,389,0005,275,0005,338,0005,191,0005,305,0005,416,0005,572,0005,782,0005,430,0006,056,0006,213,0005,605,0005,469,0005,576,0005,476,0005,228,0004,985,0005,136,0005,019,0004,689,0004,376,0004,134,0004,653,0003,916,0003,784,0003,600,0003,546,0003,277,0003,051,0002,772,0002,922,0003,698,4003,583,7002,865,4002,180,0000001,874,3000001,074,7000817,5910680,818592,621
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
795,000
822,000
810,000
900,000
998,000
1,046,000
845,000
908,000
1,470,000
1,395,000
1,360,000
1,543,000
1,542,000
1,538,000
1,502,000
1,813,000
1,452,000
1,503,000
1,514,000
1,620,000
2,132,000
2,517,000
2,314,000
2,308,000
2,398,000
2,221,000
2,212,000
2,322,000
2,261,000
2,296,000
2,268,000
2,448,000
2,318,000
2,633,000
2,437,000
2,205,000
2,099,000
1,874,000
2,065,000
2,409,000
2,817,000
1,672,000
1,544,000
3,062,000
2,353,000
1,867,000
714,000
564,000
558,000
437,000
437,000
417,000
521,000
624,000
517,000
537,000
899,000
738,000
514,000
830,000
986,000
934,000
534,000
594,000
559,000
542,000
543,000
521,000
505,000
495,000
516,000
516,000495,000505,000521,000543,000542,000559,000594,000534,000934,000986,000830,000514,000738,000899,000537,000517,000624,000521,000417,000437,000437,000558,000564,000714,0001,867,0002,353,0003,062,0001,544,0001,672,0002,817,0002,409,0002,065,0001,874,0002,099,0002,205,0002,437,0002,633,0002,318,0002,448,0002,268,0002,296,0002,261,0002,322,0002,212,0002,221,0002,398,0002,308,0002,314,0002,517,0002,132,0001,620,0001,514,0001,503,0001,452,0001,813,0001,502,0001,538,0001,542,0001,543,0001,360,0001,395,0001,470,000908,000845,0001,046,000998,000900,000810,000822,000795,00000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,422,000
45,617,000
44,704,000
44,005,000
42,446,000
42,211,000
37,576,000
37,634,000
36,603,000
36,374,000
35,698,000
35,094,000
34,607,000
33,767,000
32,801,000
31,955,000
31,956,000
31,007,000
30,663,000
30,993,000
30,475,000
29,706,000
29,706,00030,475,00030,993,00030,663,00031,007,00031,956,00031,955,00032,801,00033,767,00034,607,00035,094,00035,698,00036,374,00036,603,00037,634,00037,576,00042,211,00042,446,00044,005,00044,704,00045,617,00046,422,000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
558,375
534,140
535,272
554,137
604,500
675,400
1,077,900
1,115,800
1,168,500
1,278,200
1,292,500
1,285,100
1,328,500
1,360,900
2,062,800
2,119,500
2,137,300
2,056,000
2,288,000
2,341,000
2,426,000
2,361,000
2,638,000
2,737,000
2,741,000
3,422,000
3,493,000
3,726,000
3,861,000
3,455,000
3,737,000
3,622,000
4,228,000
4,026,000
4,591,000
4,815,000
5,560,000
5,373,000
6,083,000
6,082,000
6,281,000
5,589,000
6,291,000
6,360,000
6,501,000
5,919,000
6,665,000
6,709,000
6,551,000
5,964,000
6,349,000
6,427,000
6,422,000
6,019,000
6,632,000
6,693,000
7,763,000
7,439,000
7,572,000
7,383,000
7,317,000
7,039,000
6,805,000
6,626,000
6,563,000
6,354,000
6,782,000
6,706,000
6,495,000
6,950,000
6,710,000
6,611,000
6,709,000
6,855,000
6,641,000
6,658,000
6,547,000
6,477,000
0
6,181,000
5,990,000
6,158,000
6,171,000
6,130,000
6,028,000
6,147,000
5,982,000
5,931,000
5,931,0005,982,0006,147,0006,028,0006,130,0006,171,0006,158,0005,990,0006,181,00006,477,0006,547,0006,658,0006,641,0006,855,0006,709,0006,611,0006,710,0006,950,0006,495,0006,706,0006,782,0006,354,0006,563,0006,626,0006,805,0007,039,0007,317,0007,383,0007,572,0007,439,0007,763,0006,693,0006,632,0006,019,0006,422,0006,427,0006,349,0005,964,0006,551,0006,709,0006,665,0005,919,0006,501,0006,360,0006,291,0005,589,0006,281,0006,082,0006,083,0005,373,0005,560,0004,815,0004,591,0004,026,0004,228,0003,622,0003,737,0003,455,0003,861,0003,726,0003,493,0003,422,0002,741,0002,737,0002,638,0002,361,0002,426,0002,341,0002,288,0002,056,0002,137,3002,119,5002,062,8001,360,9001,328,5001,285,1001,292,5001,278,2001,168,5001,115,8001,077,900675,400604,500554,137535,272534,140558,375
       Goodwill 
0
0
0
0
0
560,300
0
0
0
2,572,400
0
0
0
2,462,000
7,748,500
7,882,800
7,849,600
8,038,000
8,074,000
8,101,000
8,293,000
8,407,000
8,676,000
8,670,000
8,414,000
12,297,000
12,309,000
12,218,000
12,725,000
12,674,000
12,563,000
12,223,000
15,569,000
15,232,000
15,800,000
15,926,000
15,787,000
18,293,000
18,713,000
18,369,000
18,665,000
18,856,000
18,646,000
18,589,000
18,907,000
18,981,000
18,979,000
18,948,000
18,720,000
18,408,000
17,936,000
19,257,000
19,174,000
19,025,000
20,273,000
20,700,000
40,296,000
44,409,000
45,026,000
40,035,000
39,392,000
28,414,000
28,465,000
27,648,000
27,585,000
24,917,000
24,822,000
24,913,000
24,657,000
24,846,000
24,490,000
24,616,000
20,228,000
20,624,000
20,302,000
20,421,000
20,179,000
20,040,000
19,986,000
18,837,000
18,433,000
17,633,000
17,799,000
17,118,000
16,885,000
17,177,000
17,007,000
16,488,000
16,488,00017,007,00017,177,00016,885,00017,118,00017,799,00017,633,00018,433,00018,837,00019,986,00020,040,00020,179,00020,421,00020,302,00020,624,00020,228,00024,616,00024,490,00024,846,00024,657,00024,913,00024,822,00024,917,00027,585,00027,648,00028,465,00028,414,00039,392,00040,035,00045,026,00044,409,00040,296,00020,700,00020,273,00019,025,00019,174,00019,257,00017,936,00018,408,00018,720,00018,948,00018,979,00018,981,00018,907,00018,589,00018,646,00018,856,00018,665,00018,369,00018,713,00018,293,00015,787,00015,926,00015,800,00015,232,00015,569,00012,223,00012,563,00012,674,00012,725,00012,218,00012,309,00012,297,0008,414,0008,670,0008,676,0008,407,0008,293,0008,101,0008,074,0008,038,0007,849,6007,882,8007,748,5002,462,0000002,572,400000560,30000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
283,000
0
3,000
0
83,000
0
0
0
61,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000061,00000083,00003,0000283,000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
588,326
612,578
599,364
586,216
731,300
736,500
3,186,100
3,133,400
3,129,000
3,287,200
3,254,000
3,164,900
3,177,300
3,096,600
9,845,100
9,932,100
9,858,600
10,025,000
10,032,000
10,002,000
10,220,000
10,326,000
10,631,000
10,587,000
10,370,000
16,878,000
16,673,000
16,567,000
16,957,000
16,727,000
16,435,000
15,862,000
21,450,000
20,983,000
21,912,000
22,006,000
22,035,000
28,609,000
28,213,000
27,347,000
26,960,000
26,601,000
25,977,000
25,653,000
25,911,000
25,457,000
25,309,000
25,010,000
24,656,000
23,920,000
23,179,000
27,472,000
27,234,000
26,700,000
28,839,000
30,244,000
69,853,000
65,896,000
66,215,000
61,699,000
60,270,000
46,054,000
45,779,000
16,212,000
15,345,000
14,005,000
13,191,000
12,435,000
11,878,000
11,232,000
10,256,000
9,941,000
9,308,000
8,923,000
8,445,000
8,120,000
7,832,000
7,466,000
7,116,000
6,700,000
6,394,000
6,270,000
5,964,000
5,738,000
5,525,000
5,387,000
5,056,000
4,853,000
4,853,0005,056,0005,387,0005,525,0005,738,0005,964,0006,270,0006,394,0006,700,0007,116,0007,466,0007,832,0008,120,0008,445,0008,923,0009,308,0009,941,00010,256,00011,232,00011,878,00012,435,00013,191,00014,005,00015,345,00016,212,00045,779,00046,054,00060,270,00061,699,00066,215,00065,896,00069,853,00030,244,00028,839,00026,700,00027,234,00027,472,00023,179,00023,920,00024,656,00025,010,00025,309,00025,457,00025,911,00025,653,00025,977,00026,601,00026,960,00027,347,00028,213,00028,609,00022,035,00022,006,00021,912,00020,983,00021,450,00015,862,00016,435,00016,727,00016,957,00016,567,00016,673,00016,878,00010,370,00010,587,00010,631,00010,326,00010,220,00010,002,00010,032,00010,025,0009,858,6009,932,1009,845,1003,096,6003,177,3003,164,9003,254,0003,287,2003,129,0003,133,4003,186,100736,500731,300586,216599,364612,578588,326
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
756,000
721,000
727,000
591,000
550,000
560,000
822,000
538,000
524,000
530,000
518,000
515,000
472,000
454,000
438,000
441,000
450,000
443,000
477,000
470,000
470,000
434,000
434,000470,000470,000477,000443,000450,000441,000438,000454,000472,000515,000518,000530,000524,000538,000822,000560,000550,000591,000727,000721,000756,000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
1,305,381
1,702,635
1,592,130
2,077,311
2,199,700
2,792,500
4,259,000
4,260,200
3,992,100
4,232,200
4,207,900
4,115,500
4,089,000
4,337,100
9,123,900
9,434,200
9,392,100
9,294,000
9,603,000
9,651,000
9,538,000
9,652,000
10,198,000
9,904,000
10,090,000
16,544,000
16,106,000
14,401,000
13,994,000
14,551,000
14,368,000
15,822,000
17,330,000
16,150,000
16,120,000
16,409,000
18,339,000
27,799,000
27,270,000
25,988,000
26,508,000
27,742,000
25,255,000
25,893,000
25,462,000
24,872,000
23,862,000
23,145,000
22,938,000
23,065,000
24,274,000
27,286,000
25,725,000
24,331,000
24,535,000
25,897,000
61,719,000
57,897,000
55,531,000
56,747,000
55,787,000
51,870,000
49,079,000
47,662,000
45,927,000
44,889,000
44,033,000
44,174,000
42,322,000
42,407,000
40,742,000
40,167,000
39,145,000
39,579,000
38,029,000
37,884,000
36,400,000
36,422,000
36,799,000
36,104,000
34,734,000
35,315,000
34,845,000
35,387,000
34,577,000
35,353,000
35,230,000
34,775,000
34,775,00035,230,00035,353,00034,577,00035,387,00034,845,00035,315,00034,734,00036,104,00036,799,00036,422,00036,400,00037,884,00038,029,00039,579,00039,145,00040,167,00040,742,00042,407,00042,322,00044,174,00044,033,00044,889,00045,927,00047,662,00049,079,00051,870,00055,787,00056,747,00055,531,00057,897,00061,719,00025,897,00024,535,00024,331,00025,725,00027,286,00024,274,00023,065,00022,938,00023,145,00023,862,00024,872,00025,462,00025,893,00025,255,00027,742,00026,508,00025,988,00027,270,00027,799,00018,339,00016,409,00016,120,00016,150,00017,330,00015,822,00014,368,00014,551,00013,994,00014,401,00016,106,00016,544,00010,090,0009,904,00010,198,0009,652,0009,538,0009,651,0009,603,0009,294,0009,392,1009,434,2009,123,9004,337,1004,089,0004,115,5004,207,9004,232,2003,992,1004,260,2004,259,0002,792,5002,199,7002,077,3111,592,1301,702,6351,305,381
   > Total Current Liabilities 
896,977
783,755
702,721
738,121
821,800
1,524,200
2,052,600
2,089,000
1,967,100
2,203,900
2,187,200
2,089,300
2,166,100
2,260,100
3,681,500
3,993,800
3,944,200
4,071,000
4,641,000
4,737,000
5,218,000
5,371,000
5,751,000
5,457,000
4,982,000
8,481,000
8,570,000
7,240,000
7,234,000
7,602,000
8,343,000
8,182,000
9,323,000
9,694,000
8,885,000
10,046,000
11,480,000
13,676,000
13,627,000
10,005,000
10,625,000
12,888,000
12,356,000
12,835,000
12,160,000
11,965,000
11,402,000
11,854,000
11,669,000
12,289,000
12,467,000
14,473,000
12,978,000
13,005,000
12,905,000
14,411,000
19,286,000
18,519,000
15,903,000
15,457,000
16,943,000
17,921,000
14,756,000
14,215,000
14,830,000
14,322,000
14,028,000
14,452,000
14,107,000
13,674,000
12,322,000
11,751,000
12,103,000
13,164,000
12,089,000
12,691,000
11,825,000
11,027,000
11,613,000
10,996,000
11,534,000
11,469,000
10,411,000
11,843,000
11,394,000
12,247,000
13,792,000
13,037,000
13,037,00013,792,00012,247,00011,394,00011,843,00010,411,00011,469,00011,534,00010,996,00011,613,00011,027,00011,825,00012,691,00012,089,00013,164,00012,103,00011,751,00012,322,00013,674,00014,107,00014,452,00014,028,00014,322,00014,830,00014,215,00014,756,00017,921,00016,943,00015,457,00015,903,00018,519,00019,286,00014,411,00012,905,00013,005,00012,978,00014,473,00012,467,00012,289,00011,669,00011,854,00011,402,00011,965,00012,160,00012,835,00012,356,00012,888,00010,625,00010,005,00013,627,00013,676,00011,480,00010,046,0008,885,0009,694,0009,323,0008,182,0008,343,0007,602,0007,234,0007,240,0008,570,0008,481,0004,982,0005,457,0005,751,0005,371,0005,218,0004,737,0004,641,0004,071,0003,944,2003,993,8003,681,5002,260,1002,166,1002,089,3002,187,2002,203,9001,967,1002,089,0002,052,6001,524,200821,800738,121702,721783,755896,977
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,800,000
34,636,000
35,052,000
2,418,000
3,394,000
1,300,000
1,271,000
2,672,000
2,214,000
2,790,000
2,771,000
3,130,000
2,345,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002,345,0003,130,0002,771,0002,790,0002,214,0002,672,0001,271,0001,300,0003,394,0002,418,00035,052,00034,636,00035,800,000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,800,000
34,636,000
35,052,000
2,418,000
3,394,000
1,300,000
1,271,000
2,672,000
2,214,000
2,790,000
2,771,000
3,130,000
2,345,000
1,630,000
1,649,000
2,106,000
3,188,000
2,697,000
3,530,000
2,709,000
1,426,000
2,077,000
1,719,000
2,769,000
2,109,000
1,023,000
1,980,000
1,479,000
1,672,000
3,060,000
2,094,000
2,094,0003,060,0001,672,0001,479,0001,980,0001,023,0002,109,0002,769,0001,719,0002,077,0001,426,0002,709,0003,530,0002,697,0003,188,0002,106,0001,649,0001,630,0002,345,0003,130,0002,771,0002,790,0002,214,0002,672,0001,271,0001,300,0003,394,0002,418,00035,052,00034,636,00035,800,000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
133,813
161,844
0
189,106
0
251,500
0
0
0
358,700
0
0
0
359,700
1,640,900
1,669,300
1,779,100
1,386,000
1,367,000
1,486,000
1,723,000
1,383,000
1,361,000
1,505,000
1,590,000
2,244,000
2,060,000
2,129,000
2,189,000
2,649,000
2,630,000
2,427,000
2,501,000
2,467,000
2,356,000
2,661,000
2,649,000
3,572,000
3,168,000
2,978,000
3,097,000
3,376,000
3,144,000
3,107,000
3,049,000
3,317,000
3,143,000
3,026,000
2,894,000
3,171,000
3,036,000
2,976,000
2,964,000
3,594,000
3,528,000
3,855,000
4,953,000
2,157,000
2,378,000
2,278,000
2,370,000
2,069,000
1,929,000
1,779,000
1,626,000
1,853,000
1,763,000
1,806,000
1,688,000
1,718,000
1,710,000
1,606,000
1,716,000
1,756,000
1,692,000
1,551,000
1,514,000
1,686,000
1,750,000
1,901,000
1,635,000
1,887,000
2,381,000
2,508,000
2,280,000
2,602,000
2,439,000
2,366,000
2,366,0002,439,0002,602,0002,280,0002,508,0002,381,0001,887,0001,635,0001,901,0001,750,0001,686,0001,514,0001,551,0001,692,0001,756,0001,716,0001,606,0001,710,0001,718,0001,688,0001,806,0001,763,0001,853,0001,626,0001,779,0001,929,0002,069,0002,370,0002,278,0002,378,0002,157,0004,953,0003,855,0003,528,0003,594,0002,964,0002,976,0003,036,0003,171,0002,894,0003,026,0003,143,0003,317,0003,049,0003,107,0003,144,0003,376,0003,097,0002,978,0003,168,0003,572,0002,649,0002,661,0002,356,0002,467,0002,501,0002,427,0002,630,0002,649,0002,189,0002,129,0002,060,0002,244,0001,590,0001,505,0001,361,0001,383,0001,723,0001,486,0001,367,0001,386,0001,779,1001,669,3001,640,900359,700000358,700000251,5000189,1060161,844133,813
       Other Current Liabilities 
249,103
280,389
0
342,492
0
534,200
0
0
0
1,284,800
0
0
0
1,524,900
978,800
1,268,600
1,427,900
1,943,000
1,753,000
1,727,000
1,543,000
2,147,000
2,358,000
2,523,000
2,648,000
3,331,000
3,154,000
3,083,000
3,569,000
3,652,000
3,739,000
3,809,000
4,414,000
4,456,000
4,760,000
4,927,000
5,017,000
5,824,000
6,094,000
5,607,000
6,426,000
6,506,000
6,492,000
7,194,000
6,575,000
6,844,000
6,707,000
6,780,000
6,943,000
7,357,000
7,805,000
8,475,000
7,866,000
7,826,000
7,796,000
7,674,000
10,657,000
13,086,000
11,583,000
11,933,000
11,842,000
12,206,000
11,525,000
4,131,000
3,794,000
3,710,000
773,000
899,000
821,000
4,507,000
4,575,000
4,633,000
2,894,000
2,757,000
2,636,000
2,725,000
2,501,000
2,526,000
2,448,000
2,472,000
2,370,000
2,425,000
999,000
2,341,000
1,013,000
1,056,000
1,423,000
1,545,000
1,545,0001,423,0001,056,0001,013,0002,341,000999,0002,425,0002,370,0002,472,0002,448,0002,526,0002,501,0002,725,0002,636,0002,757,0002,894,0004,633,0004,575,0004,507,000821,000899,000773,0003,710,0003,794,0004,131,00011,525,00012,206,00011,842,00011,933,00011,583,00013,086,00010,657,0007,674,0007,796,0007,826,0007,866,0008,475,0007,805,0007,357,0006,943,0006,780,0006,707,0006,844,0006,575,0007,194,0006,492,0006,506,0006,426,0005,607,0006,094,0005,824,0005,017,0004,927,0004,760,0004,456,0004,414,0003,809,0003,739,0003,652,0003,569,0003,083,0003,154,0003,331,0002,648,0002,523,0002,358,0002,147,0001,543,0001,727,0001,753,0001,943,0001,427,9001,268,600978,8001,524,9000001,284,800000534,2000342,4920280,389249,103
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,005,000
29,722,000
28,215,000
28,733,000
28,420,000
28,416,000
27,042,000
26,415,000
25,940,000
25,193,000
24,575,000
25,395,000
25,186,000
25,108,000
23,200,000
23,846,000
24,434,000
23,544,000
23,183,000
23,106,000
21,438,000
21,738,000
21,738,00021,438,00023,106,00023,183,00023,544,00024,434,00023,846,00023,200,00025,108,00025,186,00025,395,00024,575,00025,193,00025,940,00026,415,00027,042,00028,416,00028,420,00028,733,00028,215,00029,722,00030,005,000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
40,122
0
53,282
0
63,200
0
0
0
87,600
507,300
0
0
84,400
99,700
116,700
125,000
152,000
156,000
159,000
168,000
475,000
508,000
546,000
571,000
803,000
811,000
841,000
867,000
897,000
849,000
883,000
937,000
1,068,000
1,026,000
1,051,000
1,041,000
1,330,000
1,367,000
1,349,000
1,327,000
1,398,000
1,405,000
1,975,000
2,157,000
1,709,000
1,346,000
1,328,000
1,389,000
1,152,000
1,373,000
1,370,000
1,322,000
1,206,000
1,313,000
1,353,000
1,392,000
1,641,000
1,646,000
2,038,000
1,959,000
1,845,000
1,891,000
4,482,000
4,281,000
3,867,000
3,747,000
3,314,000
3,980,000
3,707,000
3,536,000
3,385,000
3,055,000
3,184,000
3,211,000
3,147,000
3,113,000
3,337,000
0
4,374,000
4,349,000
4,394,000
0
4,508,000
0
0
0
0
00004,508,00004,394,0004,349,0004,374,00003,337,0003,113,0003,147,0003,211,0003,184,0003,055,0003,385,0003,536,0003,707,0003,980,0003,314,0003,747,0003,867,0004,281,0004,482,0001,891,0001,845,0001,959,0002,038,0001,646,0001,641,0001,392,0001,353,0001,313,0001,206,0001,322,0001,370,0001,373,0001,152,0001,389,0001,328,0001,346,0001,709,0002,157,0001,975,0001,405,0001,398,0001,327,0001,349,0001,367,0001,330,0001,041,0001,051,0001,026,0001,068,000937,000883,000849,000897,000867,000841,000811,000803,000571,000546,000508,000475,000168,000159,000156,000152,000125,000116,70099,70084,40000507,30087,60000063,200053,282040,1220
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,998,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000002,998,00000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,067,662
1,151,346
1,250,347
1,380,677
1,583,700
1,829,400
4,294,800
4,506,400
5,097,400
5,388,900
5,297,800
5,310,100
5,567,100
6,042,300
9,217,600
9,901,300
10,578,500
11,142,000
11,388,000
12,058,000
12,919,000
13,724,000
14,396,000
15,075,000
14,843,000
16,300,000
16,079,000
17,815,000
19,264,000
19,222,000
19,650,000
19,328,000
21,668,000
21,947,000
23,073,000
23,685,000
22,863,000
22,195,000
23,051,000
22,751,000
22,934,000
22,768,000
22,714,000
21,515,000
22,308,000
22,565,000
22,967,000
23,540,000
23,633,000
23,313,000
22,636,000
23,038,000
22,739,000
29,769,000
30,435,000
30,150,000
35,129,000
33,337,000
34,023,000
27,994,000
28,671,000
17,359,000
18,621,000
14,178,000
13,905,000
14,707,000
14,732,000
14,122,000
13,790,000
13,972,000
13,531,000
13,852,000
9,593,000
10,026,000
10,000,000
10,324,000
10,467,000
10,278,000
9,344,000
9,037,000
8,767,000
7,897,000
7,860,000
7,052,000
6,929,000
7,506,000
7,278,000
6,359,000
6,359,0007,278,0007,506,0006,929,0007,052,0007,860,0007,897,0008,767,0009,037,0009,344,00010,278,00010,467,00010,324,00010,000,00010,026,0009,593,00013,852,00013,531,00013,972,00013,790,00014,122,00014,732,00014,707,00013,905,00014,178,00018,621,00017,359,00028,671,00027,994,00034,023,00033,337,00035,129,00030,150,00030,435,00029,769,00022,739,00023,038,00022,636,00023,313,00023,633,00023,540,00022,967,00022,565,00022,308,00021,515,00022,714,00022,768,00022,934,00022,751,00023,051,00022,195,00022,863,00023,685,00023,073,00021,947,00021,668,00019,328,00019,650,00019,222,00019,264,00017,815,00016,079,00016,300,00014,843,00015,075,00014,396,00013,724,00012,919,00012,058,00011,388,00011,142,00010,578,5009,901,3009,217,6006,042,3005,567,1005,310,1005,297,8005,388,9005,097,4004,506,4004,294,8001,829,4001,583,7001,380,6771,250,3471,151,3461,067,662
   Common Stock
0
31,030
0
31,034
0
33,900
0
0
0
42,100
0
0
0
42,600
45,500
45,600
45,700
46,000
46,000
46,000
46,000
46,000
46,000
46,000
46,000
48,000
48,000
49,000
49,000
49,000
49,000
49,000
49,000
49,000
49,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,000
52,000
52,000
52,000
54,000
54,000
54,000
54,000
54,000
54,000
54,000
54,000
54,000
56,000
56,000
56,000
56,000
56,000
56,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
0
57,000
0
0
0
0
000057,000057,00057,00057,00057,00057,00057,00057,00057,00057,00057,00057,00056,00056,00056,00056,00056,00056,00054,00054,00054,00054,00054,00054,00054,00054,00054,00052,00052,00052,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00050,00049,00049,00049,00049,00049,00049,00049,00049,00048,00048,00046,00046,00046,00046,00046,00046,00046,00046,00045,70045,60045,50042,60000042,10000033,900031,034031,0300
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000-4,146,000-4,149,000-4,149,000-4,149,000-4,150,000-4,154,000-4,156,000-4,194,000-4,196,000-4,204,000-4,207,000-4,227,000-4,252,000-4,282,000-4,315,000-3,951,000-3,511,000-3,515,000-3,542,000-3,557,000-3,568,000-3,576,000-3,280,000-3,085,000-2,593,000-2,589,000-2,455,000-1,924,000-1,772,000-1,518,000-1,423,000-1,023,000-924,000-924,000-924,000-924,000-924,000-924,000-924,000-924,000-924,000-924,000-982,000-982,000-982,000-982,000-982,000-830,000000000000000000-30,9840
   Other Stockholders Equity 0000-2,675,0000-2,838,000-3,154,000-2,801,000-2,688,000-2,683,000-2,621,000-2,446,000-2,534,000-2,400,000-2,643,000-2,703,000-2,852,000-2,312,000-2,365,000-2,312,000-2,358,000-2,459,000-2,335,000-2,289,000-1,735,000-1,853,000-2,197,000-2,400,000-2,714,000-3,159,000000000000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue15,845,000
Cost of Revenue-8,200,000
Gross Profit7,645,0007,645,000
 
Operating Income (+$)
Gross Profit7,645,000
Operating Expense-12,651,000
Operating Income3,194,000-5,006,000
 
Operating Expense (+$)
Research Development953,000
Selling General Administrative3,498,000
Selling And Marketing Expenses0
Operating Expense12,651,0004,451,000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,029,000
Other Finance Cost-66,000
Net Interest Income-1,095,000
 
Pretax Income (+$)
Operating Income3,194,000
Net Interest Income-1,095,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-624,0005,917,000
EBIT - interestExpense = -1,029,000
-559,000
470,000
Interest Expense1,029,000
Earnings Before Interest and Taxes (EBIT)0405,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-624,000
Tax Provision--7,000
Net Income From Continuing Ops-615,000-617,000
Net Income-559,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-2,723,0001,095,000
 

Technical Analysis of Teva Pharmaceutical Industries Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Teva Pharmaceutical Industries Ltd. The general trend of Teva Pharmaceutical Industries Ltd is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Teva Pharmaceutical Industries Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Teva Pharmaceutical Industries Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7,057 < 7,323.

The bearish price targets are: 6,048 > 5,988 > 5,849.

Tweet this
Teva Pharmaceutical Industries Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Teva Pharmaceutical Industries Ltd. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Teva Pharmaceutical Industries Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Teva Pharmaceutical Industries Ltd. The current macd is -127.06819726.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Teva Pharmaceutical Industries Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Teva Pharmaceutical Industries Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Teva Pharmaceutical Industries Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Teva Pharmaceutical Industries Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTeva Pharmaceutical Industries Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Teva Pharmaceutical Industries Ltd. The current adx is 21.12.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Teva Pharmaceutical Industries Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Teva Pharmaceutical Industries Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Teva Pharmaceutical Industries Ltd. The current sar is 6,537.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Teva Pharmaceutical Industries Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Teva Pharmaceutical Industries Ltd. The current rsi is 41.21. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Teva Pharmaceutical Industries Ltd Daily Relative Strength Index (RSI) ChartTeva Pharmaceutical Industries Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Teva Pharmaceutical Industries Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Teva Pharmaceutical Industries Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Teva Pharmaceutical Industries Ltd Daily Stochastic Oscillator ChartTeva Pharmaceutical Industries Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Teva Pharmaceutical Industries Ltd. The current cci is -66.4072872.

Teva Pharmaceutical Industries Ltd Daily Commodity Channel Index (CCI) ChartTeva Pharmaceutical Industries Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Teva Pharmaceutical Industries Ltd. The current cmo is -16.09025198.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Teva Pharmaceutical Industries Ltd Daily Chande Momentum Oscillator (CMO) ChartTeva Pharmaceutical Industries Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Teva Pharmaceutical Industries Ltd. The current willr is -77.21916732.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Teva Pharmaceutical Industries Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Teva Pharmaceutical Industries Ltd Daily Williams %R ChartTeva Pharmaceutical Industries Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Teva Pharmaceutical Industries Ltd. The current atr is 144.29.

Teva Pharmaceutical Industries Ltd Daily Average True Range (ATR) ChartTeva Pharmaceutical Industries Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Teva Pharmaceutical Industries Ltd. The current obv is 84,771,932.

Teva Pharmaceutical Industries Ltd Daily On-Balance Volume (OBV) ChartTeva Pharmaceutical Industries Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Teva Pharmaceutical Industries Ltd. The current mfi is 36.74.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Teva Pharmaceutical Industries Ltd Daily Money Flow Index (MFI) ChartTeva Pharmaceutical Industries Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Teva Pharmaceutical Industries Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Teva Pharmaceutical Industries Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Teva Pharmaceutical Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.207
Ma 20Greater thanMa 506,575.900
Ma 50Greater thanMa 1006,636.720
Ma 100Greater thanMa 2006,524.730
OpenGreater thanClose6,335.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Teva Pharmaceutical Industries Ltd with someone you think should read this too:
  • Are you bullish or bearish on Teva Pharmaceutical Industries Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Teva Pharmaceutical Industries Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Teva Pharmaceutical Industries Ltd

I send you an email if I find something interesting about Teva Pharmaceutical Industries Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Teva Pharmaceutical Industries Ltd.

Receive notifications about Teva Pharmaceutical Industries Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.